Prior studies demonstrate that Astrotactin (ASTN1) provides a neuronal receptor for glial-guided CNS migration. Here we report that ASTN1 binds N-cadherin (CDH2) and that the ASTN1:CDH2 interaction supports cell-cell adhesion. To test the function of ASTN1:CDH2 binding in glial-guided neuronal migration, we generated a conditional loss of Cdh2 in cerebellar granule cells and in glia. Granule cell migration was slowed in cerebellar slice cultures after a conditional loss of neuronal Cdh2, and more severe migration defects occurred after a conditional loss of glial Cdh2. Expression of a mutant form of ASTN1 that does not bind CDH2, in granule cells, also slowed migration.
INTRODUCTION
In cortical regions of mammalian brain, glial-guided neuronal migration directs postmitotic cells into neuronal layers, a process that underlies the formation of the cortical circuitry (1) (2) (3) . The cerebellar cortex has long provided a key model for understanding the molecular basis of glial-guided migration, as granule cell precursors (GCPs) migrate from the external germinal layer (EGL) along the radial processes of Bergmann glia (BG) to a position deep to the Purkinje neuron, the sole output neuron of the cerebellar cortex (4) . Correlated video and electron microscopy (EM) imaging of GCP migration along BG demonstrates that migrating neurons form a puncta adherens migration junction beneath the cell soma and extend a motile leading process in the direction of forward movement (5, 6) . During migration, the neuron forms and releases the migration junction by a process that involves endocytosis of the receptor Astrotactin (ASTN1), which is expressed in neurons but not in glia (7) . Molecular experiments demonstrate that the conserved polarity complex mPar6 regulates the cadence of locomotion by controlling the forward movement of the centrosome (8) , as well as microtubule dynamics and acto-myosin motor function in the proximal aspect of the leading process (9) , with the Rho GTPase Cdc42 controlling actin dynamics required for the polarity of the migrating GCP and for the formation of the migration junction with the glial fiber (10) . While biochemical and genetic experiments have confirmed the key role of the neuronal guidance receptor ASTN1 in the migration junction (11) (12) (13) , evidence is lacking on the glial ligand for ASTN1.
Cadherins are cell surface proteins composed of an adhesive extracellular domain and a cytoplasmic tail that links to the actin cytoskeleton through a complex of catenins.
The extracellular domain allows cadherins to form lateral (cis) homodimers or mediate cell adhesion through trans homodimers. A large body of evidence demonstrates a key role for homophilic trans cadherin interactions in the formation and maintenance of puncta adherens junctions in the developing heart and neural tube (14) , and in synapse formation (15, 16) . In addition, disruption of the neural cadherin, N-cadherin (CDH2), leads to defects in neuronal migration during development of the cerebral cortex (17) (18) (19) (20) (21) (22) .
Here we show that an asymmetric cis and trans complex of ASTN1 and CDH2 functions in neuronal migration. Conditional loss of glial CDH2 in mice impaired GCP migration in vivo and ex vivo, and perturbed the formation of a migration junction between GCPs and BG in cell-based assays. Moreover, CDH2-deficient GCPs expressing an ASTN1 variant that lacks the binding domain for CDH2 failed to migrate on CDH2-expressing glia. This suggests that ASTN1 in neurons, and CDH2 in neurons and glial fibers, form an asymmetric bridge complex that is required for glial-guided migration, and, more generally, that CDH2 might function as a heterophilic binding partner in the formation of other cell-cell junctions.
RESULTS

CDH2 is Expressed in the Migration Junction and Interacts with ASTN1.
To investigate whether CDH2 interacts with ASTN1, we performed immunoprecipitation (IP) on protein lysates from postnatal day 7 (P7) mouse cerebella using an ASTN1 antibody. In this assay, we found that ASTN1 interacts with CDH2 ( Fig.   1 A) . Similarly, in HEK 293T cells, we detected co-IP of CDH2 with full length ASTN1
CDH2 and ASTN1 Form Heterophilic Trans Interactions.
To analyze whether CDH2 interacts with ASTN1 in trans to promote cell adhesion, we used a classical S2 cell adhesion assay (24) . For this assay, we transfected S2 cells with bicistronic expression constructs (25) of Cdh2;GFP or Astn1;mCherry cDNA and measured cell aggregation rates over two hours. Cells transfected with Cdh2;GFP formed aggregates within minutes, demonstrating a rapid homophilic trans binding of CDH2 ( Fig. 2 A) . In contrast, ASTN1-positive cells did not form homophilic aggregates over the two hour incubation period. ASTN1-positive cells did, however, form co-aggregates with CDH2-positive cells, indicating heterophilic trans binding between ASTN1 and CDH2 ( Fig. 2 B) . At two hours, CDH2-positive aggregates contained 11.7 ±1.2 % ASTN1-positive cells compared to 2.6 ±0.7 % mCherry-expressing control cells (P < 0.0001). Moreover, in contrast to the control cells, ASTN1-positive cells frequently integrated into the core of the aggregates. Taken together, these results confirmed earlier findings that ASTN1 does not promote cell adhesion through homophilic binding (26) , and showed that CDH2 provides a trans ligand for ASTN1 that functions in cell-cell adhesion.
To test the specificity of the heterophilic CDH2:ASTN1 trans interaction, we measured the aggregation of ASTN1 and CDH2-positive S2 cells in the presence of Fab fragments of an ASTN1 antibody raised against the C-terminus of ASTN1 (12) . After addition of Fab fragments, heterophilic CDH2:ASTN1 trans cell adhesion was reduced to control levels ( Fig. 2 C) , suggesting that the C-terminus of ASTN1 is required for the interaction with CDH2. We then assessed the specificity of both homophilic CDH2:CDH2 and heterophilic CDH2:ASTN1 binding using a Cdh2-Δ390 construct with a deletion of the extracellular domain of CDH2. In S2 cells expressing CDH2-Δ390, both homophilic adhesion and heterophilic adhesion with ASTN1-positive cells failed ( Fig. 2 D), demonstrating a requirement for the ectodomain of CDH2 in trans cell adhesion.
Cell-Specific Deletion of Cdh2 in the Cerebellum.
To provide a genetic model for the function of CDH2 in GCP migration in the developing mouse cerebellum, we generated a conditional knockout (cKO) of Cdh2 by crossing a floxed Cdh2 (Cdh2 fl/fl ) mouse line with a NeuroD1-Cre line to delete Cdh2 in GCPs. In addition, we crossed the Cdh2 fl/fl mice with an mGFAP-Cre line to delete Cdh2 in BG, or with or an hGFAP-Cre line to delete Cdh2 in both GCPs and glia (27) (28) (29) .
Western blot analysis of lysates of GCPs and BG purified from each of the lines at P7 (30) confirmed the cell-specific deletion of Cdh2 ( Fig. S2 A) . To examine the development of the cerebellum in each of these cKO lines, we first analyzed fixed sections of P7 cerebellum by Nissl staining (Fig. S2 B -E). Although the overall size of the cerebellum did not differ significantly in the three lines (n = 7 per genotype), defects in the foliation pattern of the cerebellum of Cdh2 fl/fl ;mGFAP-Cre and Cdh2 fl/fl ;hGFAP-Cre mice were observed compared with controls. These defects included additional fissures in the ventral (I-III) lobes, with fewer fissures and irregularly shaped lobes in medio-dorsal (VI-VIII) areas.
Loss of Cdh2 in Granule Cells and/or Glia Has a Differential Effect on Migration.
Immunostaining of cerebellar sections of the three cKO lines with NeuN, a marker for GCs, and with BLBP, a marker for BG, revealed striking differences in GCP migration and formation of the neuronal layers, especially in lines where BG or both BG and GCPs lacked Cdh2 (Fig. 3 ). In all three lines, the density and organization of NeuNpositive GCPs in the EGL was identical to that seen in control mice. In Cdh2 fl/fl ;NeuroD1-Cre mice, the profile of GCPs migrating across the molecular layer was indistinguishable from controls and the overall laminar organization of the cerebellum appeared to be normal ( Fig. 3 A, B) . In contrast, NeuN-positive GCPs in the ML of both Cdh2 fl/fl ;mGFAP-Cre and Cdh2 fl/fl ;hGFAP-Cre had rounded nuclei and many GCPs were located in the ML, suggesting slowed or stalled GCP migration ( Fig. 3 C -F). Immunostaining for BLBP in these mice also revealed defects in positioning of BG cell bodies and radial patterning of BG fibers in some areas of the cerebellum ( Fig. 3 D, F). Overall, the laminar patterning of the cerebellum of mice was disorganized, as the classic boundaries of the ML and IGL were uneven relative to controls. However, immunostaining with a Calbindin antibody showed no changes in the gross morphology or positioning of Purkinje cells (data not shown). Thus, a conditional loss of Cdh2 in BG perturbed the migration of GCPs, the patterning of BG fibers and the formation of GC layers.
To quantitate the rate of GCP migration along BG fibers, we performed BrdU birth-dating experiments, injecting BrdU at P5 and sacrificing the animals at P7 (n = 4 per genotype; Fig. S3 ). By BrdU labeling, the migration distance of GCs was reduced in Cdh2 fl/fl ;NeuroD1-Cre mice where 40 ±3.7 % of labeled GCs reached the IGL compared to 50 ±3.9 % in control (P = 0.035). However, GCP migration was dramatically reduced in the Cdh2 fl/fl ;mGFAP-Cre mice, where 33 ±4.4 % reached the IGL compared to 60 ±1.9 % in control (P = 0.040). Similarly, in the Cdh2 fl/fl ;hGFAP-Cre mice, 29 ±2.9 % of GCs reached the IGL compared to 55 ±4.4 % in control (P = 0.0002). The latter two lines also had a significantly higher proportion of BrdU-labeled cells in the ML (22 % and 21 % higher than control littermates, P = 0.02 and 0.0002, respectively). These findings suggest that the expression of CDH2 in BG fibers is required for GCP migration.
Since a decrease in the number of GCs reaching the IGL could also be due to changes in cell proliferation or cell death, we stained sections with antibodies to phosphohistone H3 and the apoptosis marker Caspase-3. We found no differences in proliferation or apoptosis in the three cKO lines (data not shown), suggesting that the lower proportion of cells in the IGL resulted from migration defects.
Glial CDH2 is Essential for Granule Cell Migration in Organotypic Slice Cultures.
To analyze the features of migrating GCPs in the three cKO lines in more detail, we used electroporation to express the fluorophore Venus in GCPs in P8 organotypic slices of cerebellar cortex and imaged labeled cells by spinning disc confocal microscopy ( Fig. 4 ). In control slices, after 60 hours, Venus-positive GCs were observed in the inner EGL, ML and the outer portion of the IGL. Venus-positive cells in the inner EGL extended long parallel fiber axons, with labeled cells in the ML showing the bipolar morphology typical of migrating neurons with a leading process in the radial plane ( Fig.   4 A, C, E). Although the polarity and overall morphology of labeled GCPs in ex vivo slices of Cdh2 fl/fl ;NeuroD1-Cre cerebellum was similar to control ( Fig. 4 A, B ), the median distance of migration, calculated by measuring the distance of the cell soma to the parallel fiber axons, was reduced compared with controls (Control: 120 µm, cKO: 75 µm; P < 0.001), indicating a slowed migration rate. GCPs that expressed ASTN1 lacking the domains that bind CDH2 failed to extend a leading process and to migrate. Thus, although homophilic CDH2:CDH2 interactions may contribute to neuron-glial binding, these data demonstrate that heterophilic ASTN1:CDH2 binding is required for glial-guided neuronal migration.
Neuron-Glia Attachment is Dependent on Glial Expression of CDH2.
To directly analyze the formation of the migration junction in GCPs and BG lacking Cdh2, we generated in vitro chimeras (23, 31) . For these experiments, we purified GCPs or BG using a step gradient of Percoll (30) and mixed and matched GCPs and BG from Cdh2 fl/fl control and Cdh2 fl/fl ;hGFAP-Cre (GCP + BG cKO) cerebella.
Purified GCPs from each genotype were electroporated with either a Venus plasmid, to visualize the GCP soma and processes, or an Astn1-FL-Venus plasmid, to examine the ASTN1 protein localization, and co-cultured with purified glia from each genotype. In control cultures of wild type GCPs and BG, Venus or ASTN1-FL-Venus expressing GCPs adhered to GFAP-labeled BG fibers, formed an elongated profile along the fiber and extended a leading process in the direction of migration ( Fig. 6 A, B ). ASTN1-FL-Venus localized to the migration junction and the overexpression did not disrupt neuronglia attachment or migration. Similar results were observed in co-cultures of GCPs lacking CDH2 with control BG ( Fig. 6 C, D). A strikingly different result was seen when either control or CDH2-deficient GCPs were cultured with BG lacking CDH2. In both cases, although the ASTN1 protein localized to the basal portion of the soma, the neurons failed to form a migration junction ( Fig. 6 E -H). Measurement of the distance between the GCP soma and BG fiber confirmed this observation ( Fig. 6 I) . In addition, GCPs were rounded or multipolar, rather than elongated as seen on control BG fibers, and failed to extend a leading process. Thus, formation of the migration junction between GCPs and BG fibers required glial CDH2.
Taken together, our results propose a bridge model in which a cis complex of ASTN1 and CDH2 in the neuronal membrane interacts in trans with CDH2 on the glial fiber ( Fig. 7) to promote glial-guided migration.
DISCUSSION
This study reports evidence for the formation of a cis and trans asymmetric bridge complex between two families of CNS guidance receptors, CDH2 and ASTN1, as well as the discovery that CDH2 is the glial ligand for ASTN1, the neuronal receptor for glialguided migration. These findings are supported by biochemical evidence that ASTN1 binds CDH2 in cis, by S2 adhesion assays showing that ASTN1 binds CDH2 in trans, by genetic conditional loss of function studies showing defects in glial-guided migration in mice lacking Cdh2 in glia, and by in vitro chimeras showing a failure of GCPs to form a migration junction with glia lacking CDH2. Overexpression of an ASTN1 variant lacking the binding domain for CDH2 confirmed that homophilic CDH2 binding between GCPs and glia is not sufficient to support neuronal migration. Thus, heterophilic bridge complexes of ASTN1 and CDH2 are required for glial-guided neuronal migration in the developing cerebellum. Support for cis interactions of ASTN1 and CDH2 was provided by immunoprecipitation assays, which further confirmed that three specific extracellular domains of ASTN1 -MACPF, FNIII and ANX-like -were required for ASTN1 binding to CDH2. This finding provided the molecular basis for studies on the overexpression of ASTN1 lacking these domains, which appeared to act as a dominant negative. The biochemical findings were also supported by S2 cell adhesion assays, showing that heterophilic ASTN1:CDH2 binding supports cell-cell adhesion, in addition to homophilic CDH2-induced cell adhesion. Thus, CDH2 binds ASTN1 in both cis and trans and in intercellular adhesion. These findings are reminiscent of cis and trans binding between CDH2 and the AMPA receptor subunit GluR2 in dendritic spines (32) .
Conditional loss of function experiments have been instrumental in defining the site of action of specific neuronal or glial receptors. The significance of glial CDH2, relative to neuronal CDH2, in glial-guided migration was evident from our finding that a glial loss of Cdh2 resulted in dramatic effects on GCP morphology and a failure to adhere to glial fibers, whereas a neuronal loss of Cdh2 did not affect neuron-glia binding or stall migration. We therefore propose that the binding of ASTN1 to glial CDH2 is sufficient to promote neuron-glia attachment and glial-guided migration. The finding that a loss of Cdh2 in GCPs slowed glial-guided migration suggests that the cis interaction of ASTN1 and CDH2 is also important for migration, likely by stabilizing the migration junction between the neuron and the glial fiber. One mechanism for stabilizing the migration junction would be through endosomal recycling of ASTN1 back to the plasma membrane -a role that has previously been ascribed for ASTN2, the second member of the Astrotactin family (7) . Indeed, CDH2 has been reported to function in AMPA receptor trafficking by increasing surface expression of AMPA receptors in neurons (33) .
Interestingly, we detected an interaction of CDH2 with ASTN2 in cerebellar GCPs by co-IP (data not shown), suggesting that CDH2 is involved in the endocytic Astrotactin protein complex.
Other studies have proposed that homophilic CDH2:CDH2 binding regulates neuron-glia attachment and migration (19, 20) . Our bridge model does not exclude this scenario; however, the discrepancy in migration defects caused by the cell-specific loss of Cdh2 in neurons or glia indicates that additional proteins to CDH2 are involved in the complex. Thus, we suggest that homophilic trans CDH2 interactions contribute to the formation of a migration junction, but that the CDH2:CDH2 complex is not sufficient for migration. The present study extends the general role for cadherins in homophilic cellcell interactions by directly demonstrating that both cis and trans ASTN1:CDH2 interactions function in glial-guided migration.
Further support for the asymmetric bridge complex comes from the finding that a combined deletion of Cdh2 in both GCPs and BG produced migration defects similar to the glia-specific deletion. While the combined deletion also resulted in developmental defects in the cerebral cortex (Horn & Hatten, unpublished), this was likely due to earlier expression of the hGFAP promoter (E13.5) (29), compared to the mGFAP promoter (postnatal) (28) . Moreover, the slightly more disorganized ML/IGL boundary in the cerebellum of the Cdh2 fl/fl ;hGFAP-Cre mice was also likely attributable to the difference in promoter expression. Importantly, all migration assays in this study were comparable as they assessed GCP migration at postnatal stages (P5 -P8) where Cdh2 was deleted in all three lines ( Fig. S2 ).
Heterophilic interactions between different cadherins have been reported (34, 35) .
However, no cerebellar defects have been described in mice with a targeted deletion of R-cadherin (36), M-cadherin (37) or cadherin-11 (38), which are expressed in the postnatal mouse cerebellum (39), suggesting that these cadherins do not function in GCP migration. Still, we cannot exclude that a partial compensation of other cadherins occurred in the neuron-specific Cdh2 cKO. Interestingly, cadherin-11 was recently shown to regulate neural crest migration via binding of its cleaved EC1-3 domains to ErbB2 (40). Moreover, CDH2 has been demonstrated to interact in trans with the AMPA receptor subunit GluR2 to regulate spine formation (32) . This corroborates our findings that cell adhesion and migration can be regulated by cadherins independently of homophilic or compensatory cadherin bindings.
The heterophilic ASTN1:CDH2 interaction was shown to occur via the Cterminal ectodomain of ASTN1, which included the MACPF, FNIII and ANX-like domains ( Fig. 1 B) . We were unable to pinpoint whether a single domain binds CDH2, since ASTN1 constructs lacking only the MACPF or FNIII domains failed to localize to the cell surface. Expression of ASTN1-ΔCTD in control organotypic slices did not fully stall GCP migration, but significantly slowed migration similar to the neuronal loss of Cdh2. Slowed GCP migration is consistent with previous migration studies on Astn1 mutant mice (13). However, it is possible that endogenous ASTN1 may not have been fully competed out by ASTN1-ΔCTD and still contributed to GCP migration. In addition, we cannot exclude that other adhesion proteins are also involved in the ASTN1:CDH2 bridge complex. Nevertheless, the combined deletion of Cdh2 with ASTN1-ΔCTD expression in GCPs resulted in a migration failure similar to the glial Cdh2 cKO, demonstrating that a cis interaction of ASTN1 and CDH2 in GCPs promotes migration. This is consistent with the observation that CDH2 acts in combination with nectin-based adhesion to regulate radial glia-independent somal translocation (41).
Although the intracellular aspect of ASTN1 does not contain any domains known to be involved in intracellular signaling pathways, it is possible that the complex of ASTN1:CDH2 functions in intracellular signaling during migration. The best characterized signaling cascades involving CDH2 are beta-catenin (42) and GTPases (22, 43) . Efforts to examine a role for active beta-catenin in GCP migration were complicated by the fact that beta-catenin appears to function in both parallel fiber extension and migration, and the fact that we did not detect changes in active beta-catenin signaling in migrating GCPs of the Cdh2 mutants (Horn & Hatten, unpublished) . While recent studies support a key role for Rho, Rab and Rap GTPases in the control of CDH2 function (18, 22, 43) and in GCP migration via actin-regulatory pathways (10), their signaling role in CDH2:ASTN1 complexes remains to be determined. In addition, since prior EM studies revealed the presence of microfilaments in the migration junction (6) where ASTN1 localizes (11), it will be important to assay whether cytoskeletal elements, including actin-binding proteins, localize to the migration junction.
Our study provides the first direct demonstration of cis and trans interactions of CDH2 with a CNS migration receptor, and raises the possibility for a general function for heterophilic cadherin-receptor complexes in the formation of a wide range of cell-cell junctions. 
MATERIALS AND METHODS
Animals
DNA constructs
See SI Methods for details.
Granule cell/Bergmann glia co-cultures
Co-cultures of granule cells and Bergmann glia from P7 cerebella were prepared as described previously (30) . Briefly, dissociated cerebellar cell suspension was applied to a two-step gradient of 35 %/60 % Percoll (Sigma-Aldrich) in Tyrode's solution containing 2 mM EDTA. The Percoll gradient was centrifuged at 3000 rpm for 10 minutes at 
Organotypic slice cultures
The method is described in previous work (10) 
S2 cell adhesion assay
Drosophila Schneider 2 (S2) cells (Life Technologies) were transfected for 24 hours as described in SI Methods, and 1.5x10 6 cells from each condition were mixed together at a density of 3x10 6 cells/well (1x10 6 cells/ml) and shaken gently at 
Flow cytometry
Transfected HEK 293T cells were harvested in 1 mM EDTA in PBS. The surface fraction of Venus-linked ASTN1 variants was labeled with rabbit anti-GFP (1:5,000; Invitrogen) for 20 minutes at 4 o C followed by Alexa-647 donkey anti-rabbit (1:5,000; Life Technologies) for 25 minutes at 4 o C. Flow cytometry analysis on BD Accuri C6 (BD Biosciences) was carried out using 488 nm and 640 nm lasers as described in SI Methods.
Statistical analyses
See SI Methods for details. Differences between conditions were determined using unpaired t-tests for equal or unequal variances, except for migration distance in the slice cultures where Kruskal-Wallis and Mann-Whitney U non-parametric tests were used.
Significance was set at P < 0.05 (two-sided). In the bar diagrams, data are presented as means with error bars representing the standard deviations. The migration distance data from the slice cultures are presented in box plots.
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DNA constructs
Venus cDNA was PCR generated from pMSCXβ-Venus (8) template with the following primers: Venus forward (EcoRI) primer 5'-GAG AAG GAA TTC ACC ATG GTG AGC AAG GGC GAG GAG and Venus reverse (NotI) primer 5'-GAG AAG GCG GCC GCT TAC TTG TAC AGC TCG TCC ATG CCG (restriction sites underlined and start/stop codons in italics). The PCR product was inserted into pCIG2 plasmid (kindly provided by Dr. Franck Polleux) digested with EcoRI and NotI. The pCIG2-Astn1-Venus plasmid was generated by fusing the Venus sequence in frame with the 3' end of the Astn1 coding sequence by joining PCR. The resulting Astn1-Venus fusion insert (EcoRI/NotI) was subcloned, along with the Astn1 cDNA fragment (XmaI/EcoRI), into the pCIG2 vector. Finally, the 5' region (231 bp) of the Astn1 cDNA was inserted between the XhoI and XmaI sites. For pCIG2-Astn1-ΔCTD-Venus, the pCIG2-Astn1-Venus plasmid was digested with PstI and the larger fragment was purified. Thereafter, a gBlock DNA fragment (Integrated DNA Technologies, Coralville, IA), flanked by PstI sites and containing a fusion between Astn1 coding sequence base pair number 2160 and the Venus start site, was inserted, which generated a 1749 bp deletion of the Astn1 3' region resulting in a 583 amino acid deletion in the ASTN1 C-terminus. The pRK5-Cdh2-Myc and pRK5-Cdh2-Δ390-Myc plasmids were kindly provided by Dr. Richard Huganir. The pAc5-STABLE2-Neo plasmid containing the Drosophila Actin5C promoter (25) was kindly provided by Dr. Leslie Vosshall. To generate the pAc5-Astn1-mCherry plasmid, Astn1 cDNA was amplified by PCR with the following primers: Astn1 forward (XbaI) primer 5'-CTT TCT AGA ATG GCT TTA GCC GGG CTC TG and Astn1 reverse (XhoI) primer 5'-CTT CTC GAG CTA GAT GTC TTT GCT GTC CC (restriction sites underlined and start/stop codon in italics). The PCR product was inserted between the XbaI and XhoI sites in the pAc5-STABLE2-Neo plasmid. The pAc5-Cdh2-GFP and pAc5-Cdh2-Δ390-GFP plasmids were generated by amplifying the Cdh2 and Cdh2-Δ390 cDNA with the primers: Cdh2 forward (EcoRI) 5'-GCG AAT TCA TGT GCC GGA TAG CGG GA and Cdh2 reverse (NotI) 5'-TTG CGG CCG CTG TCG TCA CCA CCG CC (restriction sites underlined and start codon in italics). The Cdh2 and Cdh2-Δ390 PCR products were inserted into the pAc5-STABLE2-Neo plasmid digested with EcoRI and NotI. The pAc5-STABLE2-Neo plasmid contains T2A sequences to allow bicistronic expression of GFP and mCherry instead of protein fusions.
Granule cell/Bergmann glia co-cultures
Cerebella were dissected out from P7 mice and the meninges were carefully removed. The cerebella were then incubated in Trypsin-DNase for 5 minutes at 37 o C followed by gentle trituration in DNase to dissociate the tissue into single cells. The cell suspension was filtered through a 40 µm nylon mesh filter (BD Biosciences) and then applied to a two-step gradient of 35 %/60 % Percoll (Sigma-Aldrich) in Tyrode's solution containing 2 mM EDTA. The Percoll gradient was centrifuged at 3000 rpm for 10 minutes at For the glial cell fraction, the unbound cell suspension was removed and cultured on 0.1 mg/ml poly D-lysine (Millipore) pre-coated 12 mm coverslips for 1 h at 35 o C/5 % CO 2 . The plate was then tapped to dislodge granule cells that had accompanied the glial cell fraction, and the unbound cell suspension was removed. The remaining glial cells, which attached well to the coated coverslips, were cultured in granule cell medium at 35 o C/5 % CO 2 . For the granule cell fraction, the cell suspension was transferred from the petri dish to a 60 mm tissue culture dish and incubated for 30 minutes at 35 o C/5 % CO 2 . The dish was then tapped to dislodge the granule cells and the cell suspension was transferred to a new tissue culture dish and the process repeated for maximal purification of granule cells. The purified granule cells were then electroporated with an Amaxa Mouse Neuron Nucleofection kit (Lonza, Cologne, Germany), using 3x10 6 cells, 6 µg pCIG2-Venus DNA or 15 µg pCIG2-Astn1-Venus DNA, and the O-005 setting in the Amaxa Nucleofector II. Immediately after electroporation, granule cells were recovered in granule cell medium at 35 o C/5 % CO 2 for 15 minutes, centrifuged at 2000 rpm for 5 minutes at 4 o C, resuspended in granule cell medium and subsequently added to the Bergmann glia cell cultures at a ratio of 5:1 to the number of glial cells. The total numbers were ~750,000 granule cells and ~150,000 glial cells per 12 mm coverslip. The co-cultures were incubated at 35 o C/5 % CO 2 for 48 -72 h before analyzing neuron-glial attachment and granule cell migration along glial fibers.
Organotypic slice cultures
P8 cerebella from Cdh2 fl/fl and Cdh2 cKO littermates were dissected out in Hank's Balanced Salt Solution (HBSS) containing 2.5 mM HEPES (pH 7.4), 46 mM D-glucose, 1 mM CaCl 2 , 1 mM MgSO 4 , 4 mM NaHCO 3 , and Phenol Red on ice. The dissection medium was then removed and pCIG2-Venus DNA was diluted to 0.5 µg/µl and pCIG2-Astn1-FL-Venus or pCIG2-Astn1-ΔCTD-Venus DNA diluted to 1 µg/µl in HBSS. The cerebella were soaked in the DNA for 15 minutes on ice, and were then transferred one at a time into the well of an electroporation chamber (Protech International Inc. CUY520P5 platinum electrode L8xW5xH3 mm, 5 mm gap) that was placed on ice. The cerebella were electroporated dorsal to ventral for 50 ms at 80 V, for a total of 5 pulses with an interval of 500 ms between pulses, using an electro-square-porator, ECM 830 (BTX Genetronics). The cerebella were then removed from the chamber and placed on ice to recover for 10 minutes.
Subsequent to electroporation, the cerebella were embedded in 3 % agarose in HBSS, and 250 µm horizontal slices were made using a Leica VT1000S vibratome set at a speed of 3 and frequency of 6. Slices were then placed on MilliCell CM 0.4 µm culture plate inserts (Millipore) in a 6 well plate with 1.5 ml of culture medium [BME (Gibco), 25 mM Dglucose (Sigma-Aldrich), 2 mM L-glutamine (Gibco), 1X insulin/transferrin/selenium (Sigma-Aldrich), 100 U/ml penicillin/streptomycin (Gibco)] below the insert. The organotypic slices were incubated at 35 o C/5 % CO 2 for 60 hours before fixing with 4 % paraformaldehyde (PFA)/4 % sucrose in phosphate-buffered saline (PBS) for 2 hours at room temperature.
For immunostaining, the agarose was carefully removed from the slices and the slices were permeabilized and blocked overnight at µm sagittal sections were prepared using a Leica CM 3050S cryostat. The sections were postfixed in 4 % PFA in PBS for 15 min, washed in PBS, and then incubated in 2N HCl for 30 minutes at 37˚C followed by 0.1 M Sodium Borate, pH 8.5, for 10 minutes at room temperature. The sections were then processed for immunohistochemistry as described above.
Cell culture
Human embryonic kidney (HEK) 293T cells (clone 17; ATCC CRL-11268) were cultured at 37 o C/5 % CO 2 in Dulbecco's modified Eagle's medium (Gibco, cat # 11995) supplemented with 10 % fetal bovine serum (FBS; Gibco), 2 mM L-glutamine (Gibco) and 100 U/ml penicillin/streptomycin (Gibco). Cells at 50-60 % confluency were transfected with 4 µg DNA constructs using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.
Flow cytometry
Transfected HEK 293T cells were harvested in 1 mM EDTA in PBS. The surface fraction of Venus-linked ASTN1 variants was labeled with rabbit anti-GFP (1:5,000; Invitrogen) for 20 minutes at 4 o C followed by Alexa-647 donkey anti-rabbit (1:5,000; Life Technologies) for 25 minutes at 4 o C. After each antibody incubation, the cells were washed in cold 10 % NDS in PBS. Cells were stained with Propidium Iodide (100 ng/ml; Sigma-Aldrich) for dead cell exclusion. Flow cytometry analysis on BD Accuri C6 (BD Biosciences) was carried out using 488 nm and 640 nm lasers and the CFlow Sampler software (BD Biosciences). A total of 20,000 single viable cells, identified by size and lack of Propidium Iodide staining, were analyzed per condition. Gates were set using non-transfected control cells and cells expressing cytosolic Venus, which were processed for live GFP labeling as described above. Data were analyzed by FlowJo v.9.3.3 (TreeStar Inc., Ashland, OR). Identical gates were applied to each condition.
Immunoprecipitation
Transfected HEK 293T cells or whole cerebella were extracted in ice-cold lysis buffer [50 mM Tris, pH 7.4, 150 mM sodium chloride, 0.5 % sodium deoxycholate, 1 % NP-40, 1 mM EDTA and 1X protease inhibitor cocktail (Sigma-Aldrich)]. The extracts were triturated several times, incubated 20 minutes on ice and centrifuged at 14,000 rpm for 20 minutes at 4˚C. The HEK 293T protein lysates (300-400 µg) or cerebellar protein lysates (700-750 µg) were then precleared with 25 µl Protein G/A Agarose beads (Calbiochem). After removing the beads, the lysates were incubated with 3 µg of a rabbit GFP antibody (Invitrogen), rabbit Astn1 antibody, or normal rabbit IgG (Santa Cruz Biotechnology) for 2 h at 4 o C. Immunoprecipitates were collected on 50 µl Protein G/A Agarose beads by overnight rotation at 4 o C, washed with lysis buffer and resuspended in 50 µl 2X Laemmli buffer. Western blotting was performed as described below.
Western blotting
Whole cerebella or purified cerebellar granule cells and Bergmann glial cells were extracted in ice-cold lysis buffer [50 mM Tris, pH 7.4, 150 mM sodium chloride, 0.5 % sodium deoxycholate, 1 % NP-40, 1 mM EDTA and 1X protease inhibitor cocktail (Sigma-Aldrich)]. The extracts were triturated several times, incubated 20 minutes on ice and centrifuged at 14,000 rpm for 20 minutes at 4˚C. Protein concentrations were determined using the Pierce BCA Protein Assay Kit (Thermo Scientific). Protein samples in 2X Laemmli buffer were subjected to SDS-PAGE followed by transfer to Immobilon-P PVDF transfer membranes (Millipore). The membranes were blocked with 5% non-fat milk and labeled with primary and secondary antibodies in tris-buffered saline/0.1 % Tween, pH 7.6 (TBST), with each incubation for 1 h followed by washes in TBST. Primary antibodies were rabbit anti-GFP (1:10,000; Invitrogen) mouse anti-c-Myc (1:50; Calbiochem), mouse anti-N-cadherin (1:3000; BD Transduction Laboratories), rabbit anti-Astn1 (1:500) and mouse anti-GAPDH (1:10,000; Millipore). Secondary antibodies were horseradish peroxidase-conjugated anti-mouse (1:10,000; Jackson ImmunoResearch) or anti-rabbit (1:5,000; Jackson ImmunoResearch). Blots were developed with an ECL Western Blotting Detection kit (GE Healthcare) and exposed to Biomax XAR films (Carestream Health).
S2 cell adhesion assay
After transfecting the S2 cells for 24 h, 1.5x10 6 cells from each transfection were mixed together in four conditions (Fig. 2) at a density of 3x10 6 cells/well (1x10 6 cells/ml) in ultra-low attachment 6-well plates (Corning Inc.). The cells were shaken gently at 28 o C for up to 2 h to allow aggregation. Fab fragments of the Astn1 antibody were prepared and purified using Pierce Fab Micro Preparation Kit (Thermo Scientific) according to the manufacturer's instructions. The Fab fragments were concentrated to 22 µg/ml using Amicon Ultra 2 ml Ultracel-10K centrifugal filters (Millipore) and were added to the S2 cells at a final concentration of 0.4 µg/ml (12) . Cells were imaged on a Carl Zeiss Axiovert 135 fluorescent microscope with a 20X objective immediately after the conditions were set up (T = 0) and after 30 minutes, 1 h and 2 h. Longer incubations resulted in more dense cell cultures and aggregates forming in non-transfected control cells. Co-expression of the fluorophores, rather than tagged expression, ensured that they did not interfere with a potential trans binding. Cells expressing GFP (CDH2) or mCherry (control or ASTN1) were quantified in each aggregate and the proportion of mCherry-positive cells per aggregate was calculated for each condition and time point. The experiment was repeated six times.
Statistical analyses
The migration distance in the organotypic cultures ( Fig. 5 ) was calculated by measuring the distance from the parallel fibers at the edge of the slice to the granule cell soma center using the "ruler" tool in Adobe Photoshop CS6. The number of migrating cells and nonmigrating cells (round or multipolar) were quantified based on cell morphology, using the "count" tool in Adobe Photoshop CS6. In total, 700-1200 cells were quantified per control condition and 800-1300 cells per mutant condition from 5-7 slices per cerebellum (n = 3 per genotype). The neuron-glia distance (Fig. 6 ) was quantified in Adobe Photoshop CS6 by measuring the distance from the granule cell soma center to the nearest glial fiber. 30-45 cells were quantified for each condition and the experiment was repeated three times. Cerebellar size (Suppl Fig. S2 ) was measured using the freehand selection tool in ImageJ (National Institutes of Health) to encircle the whole cerebellum in midsagittal Nissl-stained sections of control and Cdh2 cKO mice (n = 7 per genotype). For BrdU experiments (Fig. S3 ), the number of BrdU-positive cells in the EGL, ML, and IGL of the cerebellar cortex of control and Cdh2 cKO mice (n = 4 per genotype) were counted using the "count" tool in Adobe Photoshop CS6 and the percentage in each layer determined. A total of 1600-2000 cells were counted per control mouse and 1500-1800 cells were counted per mutant mouse. Proliferating and apoptotic cells were quantified in phospho-histone H3 and Caspase-3 labeled sections of control and Cdh2 cKO mice (n = 7 per genotype) by counting the cells in Adobe Photoshop CS6 and dividing the number of the cells with the length (proliferation) or with the area (apoptosis) of the cerebellar lobe. Microsoft Excel 2011 and IBM SPSS Statistics v21.0 were used for the data quantifications and statistical analyses. Differences between conditions were determined using unpaired t-tests for equal or unequal variances, except for migration distance in the slice cultures where Kruskal-Wallis and Mann-Whitney U non-parametric tests were used. Significance was set at P < 0.05 (two-sided). In the bar diagrams, data are presented as means with error bars representing the standard deviations. The migration distance data from the slice cultures are presented in box plots. Fig. S1 | ASTN1-FL and ASTN1-ΔCTD are both expressed on the cell surface. Flow cytometry of live HEK 293T cells labeled with GFP and Alexa Fluor 647 antibodies. Control, untransfected cells (A) or cells transfected with Venus (B), Astn1-FL-Venus (C), or Astn1-ΔCTD-Venus, lacking the MACPF, FNIII and ANX-like domains in the C-terminus (D) . The x-axis shows total GFP fluorescence and the y-axis shows surface labeling (Alexa Fluor 647). Thus, cells expressing cytosolic Venus-tagged proteins are indicated in the lower right quadrant (Q3), while double positive cells (GFP+/Alexa Fluor 647+) in the upper right quadrant (Q2) express Venus-tagged proteins exposed on the cell surface. The percentage of cells expressing ASTN1 on the cell surface is depicted. Both ASTN1-FL and ASTN1-ΔCTD were significantly expressed on the cell surface (58 % and 49 % of live transfected cells, respectively). 
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